{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:26:03Z","timestamp":1773419163481,"version":"3.50.1"},"reference-count":52,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10,1]]},"DOI":"10.1210\/jc.2009-1399","type":"journal-article","created":{"date-parts":[[2009,9,9]],"date-time":"2009-09-09T01:34:24Z","timestamp":1252460064000},"page":"3623-3630","source":"Crossref","is-referenced-by-count":75,"title":["Update in Primary Aldosteronism"],"prefix":"10.1210","volume":"94","author":[{"given":"Michael","family":"Stowasser","sequence":"first","affiliation":[{"name":"Endocrine Hypertension Research Center, University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4102, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113421465800_R1","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline.","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113421465800_R2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample.","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113421465800_R3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/01.hjh.0000174299.66369.26","article-title":"Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity.","volume":"23","author":"So","year":"2005","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t2019041113421465800_R4","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/HJH.0b013e3283028352","article-title":"Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families.","volume":"26","author":"Sukor","year":"2008","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t2019041113421465800_R5","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041113421465800_R6","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","article-title":"Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism.","volume":"26","author":"Bernini","year":"2008","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t2019041113421465800_R7","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/HJH.0b013e3281268532","article-title":"Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension.","volume":"25","author":"Holaj","year":"2007","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t2019041113421465800_R8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1507\/endocrj.K09E-014","article-title":"Endothelial dysfunction is related to aldosterone excess and raised blood pressure.","volume":"56","author":"Tsuchiya","year":"2009","journal-title":"Endocr J"},{"key":"key\n\t\t\t\t2019041113421465800_R9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/clc.20270","article-title":"Myocardial and aortic stiffening in the early course of primary aldosteronism.","volume":"31","author":"Tsioufis","year":"2008","journal-title":"Clin Cardiol"},{"key":"key\n\t\t\t\t2019041113421465800_R10","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I.","volume":"90","author":"Stowasser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113421465800_R11","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1161\/HYPERTENSIONAHA.108.128512","article-title":"Elevated serum interleukin 6 levels in normotensive individuals with familial hyperaldosteronism type 1","volume":"53","author":"Staermose","year":"2009","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113421465800_R12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY Study.","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113421465800_R13","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1210\/jc.2008-2245","article-title":"Intrarenal hemodynamics in primary aldosteronism before and after treatment.","volume":"94","author":"Sechi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113421465800_R14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041113421465800_R15","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jc.2008-2116","article-title":"Cardio- and cerebrovascular comorbidites of hypo- and normokalemic primary aldosteronism: results of the German Conn\u2019s Registry.","volume":"94","author":"Born-Frontsberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113421465800_R16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment.","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113421465800_R17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t2019041113421465800_R18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113421465800_R19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.amjhyper.2007.03.012","article-title":"Adiponectin and insulin sensitivity in primary aldosteronism.","volume":"20","author":"Fallo","year":"2007","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t2019041113421465800_R20","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","article-title":"Fasting plasma glucose and serum lipids in patients with primary aldosteronism. A controlled cross-sectional study.","volume":"53","author":"Matrozova","year":"2009","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113421465800_R21","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ajh.2008.243","article-title":"Adrenalectomy improves arterial stiffness in primary aldosteronism.","volume":"21","author":"Strauch","year":"2008","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t2019041113421465800_R22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113421465800_R23","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1046\/j.1523-1755.2000.00983.x","article-title":"Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology.","volume":"57","author":"Delyani","year":"2000","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113421465800_R24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/14656566.9.4.509","article-title":"Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.","volume":"9","author":"Karagiannis","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"key\n\t\t\t\t2019041113421465800_R25","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s002689900552","article-title":"Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production.","volume":"22","author":"Rutherford","year":"1998","journal-title":"World J Surg"},{"key":"key\n\t\t\t\t2019041113421465800_R26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0748-7983(03)00051-9","article-title":"Review of surgical management of aldosterone secreting tumours of the adrenal cortex.","volume":"29","author":"Harris","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"key\n\t\t\t\t2019041113421465800_R27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/000313480507101015","article-title":"Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature.","volume":"71","author":"Lumachi","year":"2005","journal-title":"Am Surg"},{"key":"key\n\t\t\t\t2019041113421465800_R28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00000658-196308000-00006","article-title":"Primary aldosteronism: diagnosis and surgical treatment.","volume":"158","author":"Gilbert","year":"1963","journal-title":"Ann Surg"},{"key":"key\n\t\t\t\t2019041113421465800_R29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0002-9343(70)90065-3","article-title":"The syndrome of primary aldosteronism.","volume":"48","author":"George","year":"1970","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113421465800_R30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-90-3-386","article-title":"Primary aldosteronism: diagnosis, localization, and treatment.","volume":"90","author":"Weinberger","year":"1979","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113421465800_R31","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","article-title":"Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience.","volume":"94","author":"Sukor","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113421465800_R32","first-page":"319","article-title":"Aldosterone synthase inhibitors: pharmacological and clinical aspects.","volume":"10","author":"Jansen","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"key\n\t\t\t\t2019041113421465800_R33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism.","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113421465800_R34","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome.","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113421465800_R35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","article-title":"Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure.","volume":"61","author":"Oelkers","year":"1996","journal-title":"Steroids"},{"key":"key\n\t\t\t\t2019041113421465800_R36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.ten.0000139006.29471.9e","article-title":"The aldosterone-renin ratio for screening for primary aldosteronism.","volume":"14","author":"Stowasser","year":"2004","journal-title":"Endocrinologist"},{"key":"key\n\t\t\t\t2019041113421465800_R37","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.amjhyper.2007.08.009","article-title":"Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy.","volume":"20","author":"Pizzolo","year":"2007","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t2019041113421465800_R38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/jhh.2008.109","article-title":"The ovarian cycle as a factor of variability in the laboratory screening for primary aldosteronism in women.","volume":"23","author":"Fommei","year":"2009","journal-title":"J Hum Hypertens"},{"key":"key\n\t\t\t\t2019041113421465800_R39","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","article-title":"Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement.","volume":"55","author":"Campbell","year":"2009","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041113421465800_R40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","article-title":"Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma.","volume":"50","author":"Rossi","year":"2007","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113421465800_R41","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1161\/HYPERTENSIONAHA.107.093468","article-title":"Captopril test can give misleading results in patients with suspect primary aldosteronism","volume":"50","author":"Mulatero","year":"2007","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113421465800_R42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1521-690X(03)00050-2","article-title":"Primary aldosteronism.","volume":"17","author":"Stowasser","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113421465800_R43","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1089\/end.2008.0007","article-title":"Usefulness of adrenal vein sampling in the evaluation of aldosteronism.","volume":"22","author":"Schwab 2nd","year":"2008","journal-title":"J Endourol"},{"key":"key\n\t\t\t\t2019041113421465800_R44","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1373\/clinchem.2007.092080","article-title":"Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism.","volume":"53","author":"Mengozzi","year":"2007","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041113421465800_R45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/HYPERTENSIONAHA.108.128553","article-title":"Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols.","volume":"53","author":"Seccia","year":"2009","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113421465800_R46","first-page":"455","article-title":"Primary aldosteronism: part II: subtype differentiation and treatment.","volume":"21","author":"Rossi","year":"2008","journal-title":"J Nephrol"},{"key":"key\n\t\t\t\t2019041113421465800_R47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2265.2008.03450.x","article-title":"What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism?","volume":"70","author":"Young","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113421465800_R48","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1373\/clinchem.2006.068502","article-title":"Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps.","volume":"52","author":"Schirpenbach","year":"2006","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041113421465800_R49","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1373\/clinchem.2008.116004","article-title":"Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry.","volume":"55","author":"Taylor","year":"2009","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041113421465800_R50","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmg.37.11.831","article-title":"A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).","volume":"37","author":"Lafferty","year":"2000","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t2019041113421465800_R51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1440-1681.2008.04882.x","article-title":"Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II.","volume":"35","author":"Jeske","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"key\n\t\t\t\t2019041113421465800_R52","first-page":"S448","article-title":"Examination of chromosome 7p22 candidate genes RPA3, ZNF12 and GLCCI1 in familial hyperaldosteronism type II","volume":"27","author":"Sukor","year":"2009","journal-title":"J Hypertens"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/10\/3623\/9056888\/jcem3623.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T12:38:42Z","timestamp":1633869522000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/10\/3623\/2596401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,1]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-1399","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,1]]}}}